Skip to content

Mifamurtide

Mepact (mifamurtide) is a small molecule pharmaceutical. Mifamurtide was first approved as Mepact on 2009-03-06. It has been approved in Europe to treat osteosarcoma.
Trade Name Mepact
Common Name Mifamurtide
Indication osteosarcoma
Drug Class Peptides: peptides with muranic acid present
Mifamurtide
Get full access now